Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 15 studies | 26% ± 11% | |
macrophage | 14 studies | 25% ± 9% | |
conventional dendritic cell | 14 studies | 22% ± 5% | |
myeloid cell | 8 studies | 26% ± 8% | |
plasma cell | 7 studies | 27% ± 7% | |
dendritic cell | 7 studies | 34% ± 12% | |
monocyte | 6 studies | 30% ± 7% | |
classical monocyte | 5 studies | 23% ± 4% | |
non-classical monocyte | 5 studies | 22% ± 8% | |
endothelial cell | 5 studies | 20% ± 6% | |
hepatocyte | 5 studies | 71% ± 18% | |
abnormal cell | 4 studies | 20% ± 5% | |
epithelial cell | 3 studies | 36% ± 11% | |
retina horizontal cell | 3 studies | 23% ± 3% | |
ciliated cell | 3 studies | 24% ± 6% | |
inflammatory macrophage | 3 studies | 31% ± 2% | |
plasmablast | 3 studies | 26% ± 7% | |
mononuclear phagocyte | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 5 studies | 32% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1386.04 | 653 / 653 | 100% | 61.09 | 605 / 605 |
skin | 100% | 2753.89 | 1805 / 1809 | 100% | 49.46 | 471 / 472 |
adrenal gland | 100% | 3557.87 | 258 / 258 | 100% | 61.45 | 229 / 230 |
ovary | 100% | 1024.51 | 180 / 180 | 100% | 71.74 | 428 / 430 |
prostate | 100% | 1832.46 | 245 / 245 | 99% | 65.09 | 499 / 502 |
liver | 100% | 102007.62 | 226 / 226 | 99% | 434.36 | 401 / 406 |
breast | 100% | 2621.36 | 459 / 459 | 99% | 51.88 | 1103 / 1118 |
kidney | 100% | 1632.44 | 89 / 89 | 98% | 35.19 | 882 / 901 |
uterus | 99% | 1137.04 | 168 / 170 | 99% | 70.80 | 454 / 459 |
intestine | 100% | 1363.39 | 964 / 966 | 98% | 35.82 | 515 / 527 |
bladder | 100% | 1866.14 | 21 / 21 | 97% | 52.87 | 491 / 504 |
esophagus | 100% | 1627.94 | 1439 / 1445 | 98% | 34.26 | 179 / 183 |
lung | 99% | 1281.54 | 574 / 578 | 98% | 57.87 | 1127 / 1155 |
stomach | 100% | 1375.64 | 359 / 359 | 96% | 35.71 | 275 / 286 |
pancreas | 98% | 1102.73 | 320 / 328 | 98% | 33.43 | 175 / 178 |
brain | 97% | 945.45 | 2558 / 2642 | 92% | 27.16 | 651 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 36.37 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 329.04 | 29 / 29 |
spleen | 100% | 1958.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 100.13 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.72 | 1 / 1 |
adipose | 100% | 2697.56 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1295.32 | 1329 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1185.63 | 793 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 781.99 | 805 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 3946.99 | 750 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0009791 | Biological process | post-embryonic development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0046605 | Biological process | regulation of centrosome cycle |
GO_0035264 | Biological process | multicellular organism growth |
GO_1902750 | Biological process | negative regulation of cell cycle G2/M phase transition |
GO_0007623 | Biological process | circadian rhythm |
GO_0021891 | Biological process | olfactory bulb interneuron development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0021930 | Biological process | cerebellar granule cell precursor proliferation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045444 | Biological process | fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0015631 | Molecular function | tubulin binding |
GO_0019900 | Molecular function | kinase binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ATF5 |
Protein name | Cyclic AMP-dependent transcription factor ATF-5 (cAMP-dependent transcription factor ATF-5) (Activating transcription factor 5) (Transcription factor ATFx) Activating transcription factor 5 |
Synonyms | ATFX |
Description | FUNCTION: Transcription factor that either stimulates or represses gene transcription through binding of different DNA regulatory elements such as cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), ATF5-specific response element (ARE) (consensus: 5'-C[CT]TCT[CT]CCTT[AT]-3') but also the amino acid response element (AARE), present in many viral and cellular promoters. Critically involved, often in a cell type-dependent manner, in cell survival, proliferation, and differentiation . Its transcriptional activity is enhanced by CCND3 and slightly inhibited by CDK4 . Important regulator of the cerebral cortex formation, functions in cerebral cortical neuroprogenitor cells to maintain proliferation and to block differentiation into neurons. Must be down-regulated in order for such cells to exit the cycle and differentiate (By similarity). Participates in the pathways by which SHH promotes cerebellar granule neuron progenitor cells proliferation (By similarity). Critical for survival of mature olfactory sensory neurons (OSN), directs expression of OSN-specific genes (By similarity). May be involved in osteogenic differentiation . Promotes cell proliferation and survival by inducing the expression of EGR1 sinergistically with ELK1. Once acetylated by EP300, binds to ARE sequences on target genes promoters, such as BCL2 and EGR1 . Plays an anti-apoptotic role through the transcriptional regulation of BCL2, this function seems to be cell type-dependent (By similarity). Cooperates with NR1I3/CAR in the transcriptional activation of CYP2B6 in liver . In hepatic cells, represses CRE-dependent transcription and inhibits proliferation by blocking at G2/M phase . May act as a negative regulator of IL1B transduction pathway in liver . Upon IL1B stimulus, cooperates with NLK to activate the transactivation activity of C/EBP subfamily members . Besides its function of transcription factor, acts as a cofactor of CEBPB to activate CEBPA and promote adipocyte differentiation . Regulates centrosome dynamics in a cell-cycle- and centriole-age-dependent manner. Forms 9-foci symmetrical ring scaffold around the mother centriole to control centrosome function and the interaction between centrioles and pericentriolar material . . |
Accessions | ENST00000596658.1 ENST00000597227.5 M0R0D5 M0R040 ENST00000600336.1 ENST00000595125.5 ENST00000423777.7 M0QZD2 Q9Y2D1 |